5AM Ventures VI, L.P.

This profile gathers the share dealings of 5AM Ventures VI, L.P. across 2 companies, led by Latigo Biotherapeutics, Inc. and Vor Biopharma Inc. Over a trading history stretching from 16 November 2021 to 10 August 2026, the count stands at 3 filings.

Every open-market trade on record is a sale: 1 sale worth €3.2M.

Most recently, on 12 August 2026, the filings show a transaction in Latigo Biotherapeutics, Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.